Knockdown of PDIA3P1 in resistant cell lines (U118MG and U87MG) resulted in a notable reduction in IC50 and further inhibition of the tumor cell growth rate upon TMZ treatment (Fig. 1D and Fig. S1E). Here, PDIA3P1 is linked to neoplasm.